Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients
Introduction: Oral isotretinoin is an effective agent for the treatment of severe cystic acne. Isotretinoin is a teratogen; there is an increased risk of congenital defects in infants exposed to the drug in the uterus. The Saudi Food and Drug Authority (SFDA) has implemented a pregnancy prevention p...
Saved in:
| Main Authors: | Alnada Abdalla Mohamed Ibrahim, Amal Almotiry Alshatri, Salem Alsuwaidan, Lulu Almutairi, Nasser Aljasser, Mansour Adam Mahmoud, Afnan Alaseeri, Abrar Almonysir, Badraa Alotaibi, Batoul Alrasheed, Maram Alfawaz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2021-06-01
|
| Series: | Saudi Pharmaceutical Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016421000700 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Termination of Pregnancy Following Periconception Isotretinoin Exposure in South Korea
by: Young-Rae Lee, et al.
Published: (2024-06-01) -
Isotretinoin use in rhinoplasty patients
by: Jholbert Cardoso Santana, et al.
Published: (2025-07-01) -
Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study
by: UYeong Choi, et al.
Published: (2025-12-01) -
Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights
by: Fawaz Aljehani, et al.
Published: (2024-12-01) -
Isotretinoin-LIDOSE: 15 years of experience in acne therapy. A review
by: Luiza R. Sakaniya, et al.
Published: (2025-01-01)